LabCompass

Richard D. DiMarchi

Medicine · Indiana University

OpenAlex ORCID
Established · publishing since 1978
Diabetes Treatment and ManagementPancreatic function and diabetesRegulation of Appetite and ObesityMetabolism, Diabetes, and CancerReceptor Mechanisms and Signaling

Publications

295

Citations

20,423

Est. group size

—

Recurring co-author estimate

Active years

49

Publishing since 1978

Research summary
AI-generated

Richard D. DiMarchi designs engineered peptide and protein drugs that target the hormone receptors controlling blood sugar, appetite, and body weight. Much of the work focuses on molecules that act on multiple receptors at once (such as GLP-1, GIP, and glucagon receptors) to treat obesity, type 2 diabetes, and related metabolic conditions, along with modified insulin formulations and other hormone analogs.

Multi-receptor peptide drugs for obesity and diabetesIncretin hormone receptor agonists and antagonists (GLP-1, GIP, glucagon)Long-acting and engineered insulin therapiesPeptide and protein medicinal chemistryMetabolic and hormone receptor signaling

Publication output was highest in the late 2010s (around 18-22 per year) and has trended downward since, averaging about 10 papers per year over the last five years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

In context
Among 5,073 established Medicine PIs within our index
Citations: 20,423cohort median 2,525
h-index: 73cohort median 24
Publications / year (recent): 9.8cohort median 4.8

Typically publishes in teams of ~8 · 8% small-team papers (≤3 authors) · across 61 venues

Publication cadence
Publications per year over the last 10 years — averaging 9.8/year recently
2017: 18 publications172018: 22 publications22182019: 21 publications192020: 17 publications202021: 13 publications212022: 12 publications222023: 5 publications232024: 14 publications242025: 11 publications252026: 7 publications26
Collaborators per year
Distinct co-authors at Indiana University each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
2017: 0 collaborators at the same institution2018: 0 collaborators at the same institution2019: 0 collaborators at the same institution2020: 0 collaborators at the same institution2021: 0 collaborators at the same institution2022: 0 collaborators at the same institution2023: 0 collaborators at the same institution2024: 0 collaborators at the same institution2025: 1 collaborator at the same institution1719212325
Recent publications
Publishes in
  • Molecular Metabolism×21
  • Diabetes×14
  • Cell Metabolism×6
  • Nature Metabolism×6
  • Journal of Medicinal Chemistry×6
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Sep 1, 2026.

Claim or correct this profile